tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals (APLS)
NASDAQ:APLS
US Market

Apellis Pharmaceuticals (APLS) Cash flow

Compare
985 Followers

Apellis Pharmaceuticals Cash Flow

APLS's free cash flow for Q3 2025 was $108.32M. For the 2025 fiscal year, APLS's free cash flow was decreased by $507.24M and operating cash flow was $108.47M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -87.87M$ -594.74M$ -513.75M$ -563.13M$ -160.49M
Investing Cash Flow
$ -403.00K$ -674.00K$ 59.89M$ 247.62M$ -316.99M
Financing Cash Flow
$ 149.24M$ 394.50M$ 365.66M$ 392.24M$ 692.18M
End Cash Position
$ 412.61M$ 352.30M$ 553.07M$ 641.75M$ 567.04M
Free Cash Flow
$ -88.27M$ -595.51M$ -515.27M$ -564.23M$ -165.91M
Currency in USD

Apellis Pharmaceuticals Cash Flow